Again, this highlights the fact that samples can contain small subpopulations of cells, in this case the 6% or so of AML cells in the S/G2/M phase of the cell cycle, which have dramatically different properties, or in which c-Myb is associated with totally different sets of target genes. The gene discussed is MYB; the disease is acute myeloid leukemia.